A-Cube
Announcement of Exhibition at the 33rd Annual Meeting of the Japan Sjögren’s Syndrome Society (Ongoing)
The 33rd Annual Meeting of the Japan Sjögren’s Syn…
NEWS Index
NEWS
ProteoBridge Announces Third-Party Allotment to Strengthen Research Testing Services and Advance New Product Development
ProteoBridge Inc. is pleased to announce that it h…
A-Cube
34th A-Cube® Research Test Seminar Announcement
The 34th A-Cube® Research Test Seminar will be hel…
NEWS
ProteoBridge Inc. Representative Appointed as Director of the Japan Bioinformatics Consortium (JBIC)
ProteoBridge Inc. (Head Office: Koto-ku, Tokyo) is…
A-Cube
Our Technology Featured in Allergy & Rheumatic Diseases September 2025 Issue – Special Feature on “Allergen Immunotherapy”
In the September 2025 issue of Allergy & Rheum…
A-Cube
🎉 The 11th Annual Meeting of the Japanese Society of Myology Has Officially Begun!
At our booth, we are showcasing a wide range of se…
HuPEX
HuPEX®-Powered Proteomics Research Published in Journal of Proteome Research
Tokyo, Japan – July 25, 2025 – ProteoBridge Inc. (…
Conferences and Exhibitions
Proteo-Bridge Inc. Exhibiting at the Corporate Booth of the “2025 Japan Health JETRO Pavilion”
Proteo-Bridge Inc. is pleased to announce our part…
A-Cube
[New Service Announcement] Launch of Paraneoplastic Neurological Syndrome-Related Antibody Detection Set (Research Use Only)
~ Cutting-edge technology enables simultaneous tes…
award
Certified as an AISol startup.
Proteobridge Co., Ltd. has been certified as an AI…